Partner Fund Management as of Dec. 31, 2015
Portfolio Holdings for Partner Fund Management
Partner Fund Management holds 67 positions in its portfolio as reported in the December 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bristol Myers Squibb (BMY) | 6.0 | $196M | 2.9M | 68.79 | |
Walgreen Boots Alliance (WBA) | 5.9 | $193M | 2.3M | 85.15 | |
Allergan | 4.7 | $154M | 493k | 312.50 | |
Palo Alto Networks (PANW) | 4.4 | $144M | 819k | 176.14 | |
Aercap Holdings Nv Ord Cmn (AER) | 3.8 | $126M | 2.9M | 43.16 | |
Teva Pharmaceutical Industries (TEVA) | 3.7 | $122M | 1.9M | 65.64 | |
Alphabet Inc Class A cs (GOOGL) | 3.2 | $107M | 138k | 778.01 | |
Amazon (AMZN) | 3.0 | $99M | 147k | 675.89 | |
Vulcan Materials Company (VMC) | 3.0 | $97M | 1.0M | 94.97 | |
Edwards Lifesciences (EW) | 2.8 | $93M | 1.2M | 78.98 | |
Charles Schwab Corporation (SCHW) | 2.8 | $92M | 2.8M | 32.93 | |
Alibaba Group Holding (BABA) | 2.6 | $86M | 1.1M | 81.27 | |
Medicines Company | 2.3 | $77M | 2.1M | 37.34 | |
Heron Therapeutics (HRTX) | 2.2 | $74M | 2.8M | 26.70 | |
Clovis Oncology | 2.2 | $73M | 2.1M | 35.00 | |
Jazz Pharmaceuticals (JAZZ) | 2.2 | $72M | 512k | 140.56 | |
Universal Health Services (UHS) | 2.1 | $69M | 574k | 119.49 | |
Textron (TXT) | 2.0 | $66M | 1.6M | 42.01 | |
Lam Research Corporation (LRCX) | 1.9 | $64M | 805k | 79.42 | |
Alder Biopharmaceuticals | 1.9 | $62M | 1.9M | 33.03 | |
Bristol-myers Squibb | 1.8 | $60M | 877k | 68.79 | |
Synchrony Financial (SYF) | 1.8 | $60M | 2.0M | 30.41 | |
Aerie Pharmaceuticals | 1.8 | $58M | 2.4M | 24.35 | |
Aetna | 1.7 | $57M | 523k | 108.12 | |
Hologic (HOLX) | 1.7 | $55M | 1.4M | 38.69 | |
Acorda Therapeutics | 1.7 | $55M | 1.3M | 42.78 | |
Facebook Inc cl a (META) | 1.7 | $55M | 525k | 104.66 | |
Fortune Brands (FBIN) | 1.5 | $50M | 898k | 55.50 | |
Netflix (NFLX) | 1.5 | $49M | 427k | 114.38 | |
BlackRock (BLK) | 1.3 | $44M | 129k | 340.52 | |
Bluebird Bio (BLUE) | 1.3 | $43M | 668k | 64.22 | |
Servicenow (NOW) | 1.3 | $42M | 482k | 86.56 | |
Macquarie Infrastructure Company | 1.2 | $41M | 564k | 72.60 | |
Home Depot (HD) | 1.1 | $37M | 277k | 132.25 | |
Molina Healthcare (MOH) | 1.1 | $35M | 588k | 60.13 | |
Accuray Incorporated (ARAY) | 1.1 | $35M | 5.1M | 6.75 | |
Kite Pharma | 1.0 | $34M | 556k | 61.62 | |
United Rentals (URI) | 0.9 | $29M | 397k | 72.54 | |
Microsoft Corporation (MSFT) | 0.8 | $27M | 492k | 55.48 | |
Hca Holdings (HCA) | 0.8 | $27M | 402k | 67.63 | |
Charter Communications | 0.8 | $27M | 145k | 183.10 | |
Blueprint Medicines (BPMC) | 0.8 | $27M | 1.0M | 26.34 | |
Theravance | 0.7 | $24M | 2.3M | 10.54 | |
Hortonworks | 0.7 | $24M | 1.1M | 21.90 | |
Global Blood Therapeutics In | 0.7 | $23M | 704k | 32.33 | |
UnitedHealth (UNH) | 0.6 | $21M | 175k | 117.64 | |
Celgene Corporation | 0.6 | $19M | 160k | 119.76 | |
Voyager Therapeutics (VYGR) | 0.5 | $17M | 897k | 19.06 | |
Rite Aid Corporation | 0.5 | $15M | 1.9M | 7.84 | |
Zeltiq Aesthetics | 0.5 | $15M | 514k | 28.53 | |
McKesson Corporation (MCK) | 0.4 | $14M | 73k | 197.23 | |
Dex (DXCM) | 0.4 | $14M | 176k | 81.90 | |
Kura Oncology (KURA) | 0.4 | $13M | 1.5M | 8.40 | |
Clovis Oncology | 0.3 | $11M | 325k | 35.00 | |
Orexigen Therapeutics Inc. 144a 2 3/4% Due 12/1/2020 Jd1 note 2.750%12/0 | 0.3 | $10M | 17M | 0.60 | |
Myokardia | 0.3 | $10M | 699k | 14.66 | |
AMAG Pharmaceuticals | 0.3 | $8.5M | 282k | 30.19 | |
Dimension Therapeutics | 0.2 | $8.4M | 815k | 10.28 | |
Gilead Sciences (GILD) | 0.2 | $6.7M | 66k | 101.18 | |
Juno Therapeutics | 0.2 | $6.6M | 151k | 43.97 | |
Coherus Biosciences (CHRS) | 0.1 | $4.0M | 173k | 22.96 | |
Clovis Oncology Inc note 2.500% 9/1 | 0.1 | $4.0M | 4.6M | 0.86 | |
Atlassian Corp Plc cl a | 0.1 | $3.0M | 98k | 30.08 | |
Penumbra (PEN) | 0.1 | $2.5M | 47k | 53.81 | |
Sage Therapeutics (SAGE) | 0.1 | $2.4M | 41k | 58.31 | |
Regenxbio Inc equity us cm (RGNX) | 0.1 | $2.0M | 119k | 16.60 | |
MaxLinear (MXL) | 0.0 | $1.2M | 81k | 14.73 |